Engaging Disparities in Prostate Cancer Care (2021)

June 28, 2021

Click HERE for more information or to REGISTER for the Engaging Disparities In Prostate Cancer Care Virtual Workshop scheduled for November 16, 2021! 

REGISTER NOW for the first educational offering of this initiative, the Engaging Disparities in Prostate Cancer Care - Live Webinar!

  • Attend live on Monday, June 28, 2021 from 3:30 - 4:30 pm Eastern Time.
  • Interact and Engage with master Faculty throughout the program as they discuss the essentials of Shared Decision Making (SDM).
    • Course Director/Moderator: Willie Underwood, III, MD, FACS, MPH, MSc
    • Faculty/Panelists: Otis Webb Brawley, Jr., MD; Kelvin A. Moses, MD, PhD
  • Explore prior research findings in SDM concepts, related evaluation measures, and steps to achieve SDM. 
  • Increase your participation in SDM and how to implement it in your practice, particularly in underserved communities.

    Engaging Disparities in Prostate Cancer Care consists of multiple educational activities featuring a variety of formats for the urologic healthcare team. These activities will reinforce the essentials of Shared Decision Making (SDM) to better assist high-risk patients in regards to prostate cancer screening and treatment. A live webinar, three episode podcast series, and Clinical Problem Solving (CPS) Protocol will enable participants to be better prepared to apply SDM in their practice and comply with the recently proposed USPSTF Grade C recommendation for PSA screening. The latest research documenting the benefits and drawbacks of PSA screening as well as treatment approaches for incident localized prostate cancer will be incorporated. 

    These complimentary educational offerings are intended for a wide-range of health practitioners, both experienced and new to the field, as well as graduate trainees. Learners will hear, observe, evaluate, practice, and role-play SDM strategies and culturally sensitive scenarios for prostate cancer screening and treatment decisions. Activities will offer not only didactic information, but also interactive training sessions with a focus on recommended strategies for improving SDM, participants' attitudes towards SDM, knowledge about SDM, implicit and explicit biases in SDM, and skills for multi-level SDM (i.e. patient and family caregivers). 

      ACKNOWLEDGEMENTS:

      Support provided by independent educational grants from:

      • Astellas
      • Bayer HealthCare Pharmaceuticals Inc.
      • Genentech
      • Janssen Biotech, Inc., administered by Janssen Scientific Affairs, LLC.
      • Merck
      • Pfizer, Inc.

      Target Audience

      • Urologist
      • Resident
      • Advanced Practice Provider (Nurse Practitioners & Physician Assistants)

        Learning Objectives

        At the conclusion of this educational series, the learner will:

        1. Discuss the impact of SDM on patients and on patient-clinician communication.
        2. Identify at least one implementation strategy for using SDM in clinical practice.
        3. Apply SDM techniques in a role-playing exercise with other colleagues.
        4. Incorporate culturally sensitive communications to ensure quality SDM and reduce biases.
        5. Utilize the knowledge and experience they have gained through role-play into their routine practice-counseling patients.
        Course summary
        Available credit: 
        • 1.00 AMA PRA Category 1 Credit™
        • 1.00 Non-Physician Participation
        Course opens: 
        05/31/2021
        Course expires: 
        06/28/2024
        Event starts: 
        06/28/2021 - 3:30pm EDT
        Event ends: 
        06/28/2021 - 4:30pm EDT
        Add to calendar: 
        Rating: 
        0

        Engaging Disparities in Prostate Cancer Care (2021) - Live Webinar

        Monday, June 28, 2021 | 3:30 - 4:30 p.m. (EDT)

        Agenda

        3:30 - 3:32 p.m.            Welcome       

        3:32 - 3:37 p.m.            Knowledge Assessment (Pre-Test) – Willie Underwood, III, MD

        3:37 - 3:40 p.m.            Learning Objectives/Introduction of Panelists – Willie Underwood, III, MD

        3:40 - 4:20 p.m.            Interview-Style Discussion

                                                 Moderator: Willie Underwood, III, , MD

                                                 Panelists: Otis Webb Brawley, Jr., MD; Kelvin A. Moses, MD, PhD

        • Segment #1: The Impact of Shared Decision Making (SDM) on Patients and on Patient-Clinician Communication 
        • Segment #2: Implementation Strategies for Using SDM in Clinical Practice.
        • Segment #3: Best Practices for Incorporating Culturally Sensitive Communications to Ensure Quality SDM and Reduce Biases 

        4:20 - 4:30 p.m.           Live Q&A 

                                                 Moderator: Willie Underwood, III, , MD

                                                 Panelists: Otis Webb Brawley, Jr., MD; Kelvin A. Moses, MD, PhD

        4:30 p.m.                       Webinar Concludes 

        Engaging Disparities in Prostate Cancer Care will be held on Monday, June 28, 2021 from 3:30 - 4:30 p.m. ET. 

        ***Instructions***

        1. Click the "Register" tab.
        2. If prompted, click “update your profile”.  Otherwise, click “Take Course”.
        3. Click "Participant Instructions" and then "Start".  You will then be provided with full details on how to access the audio and web (video) components of the webinar.

        Education Council Disclosures

        PDF icon Education Council Disclosures 2021

        COI Review Work Group Disclosures

        PDF iconCOI Review Work Group Disclosures 2021

        All relevant financial relationships have been mitigated. 

        AUA Office of Education Staff has nothing to disclose.

        Course Director(s)

        Willie Underwood, MD, FACS, MPH, MSc

        has a financial relationship (Independent contractor) with HealthNow (BCBS of WNY and NENY);.
        has a financial relationship (Other) with KAPS BIOTECH;.
        has a financial relationship (Other) with Pfizer Pharmaceutical ;.
        Faculty(s)

        Otis Brawley, MD

        has a financial relationship (Independent contractor) with Grail;.
        has a financial relationship (Independent contractor) with Cancer History Project;.
        has a financial relationship (Independent contractor) with Lyell Immunopharma;.
        has a financial relationship (Independent contractor) with PDS Biosciences;.
        has a financial relationship (Independent contractor) with Genentech/Roche;.

        Kelvin Moses, MD

        has a financial relationship (Independent contractor) with Pfizer;.
        has a financial relationship (Independent contractor) with Dendreon;.
        has a financial relationship (Independent contractor) with Astellas;.

        ACCREDITATION: 

        The American Urological Association (AUA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

        CREDIT DESIGNATION: 

        The American Urological Association designates this live and enduring activity for a maximum of 5.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

        OTHER LEARNERS: 

        The AUA is not accredited to offer credit to participants who are not MDs or DOs. However, the AUA will issue documentation of participation that states that the activity was certified for AMA PRA Category 1 Credit™.

        EVIDENCE BASED CONTENT: 

        It is the policy of the AUA to ensure that the content contained in this CME activity is valid, fair, balanced, scientifically rigorous, and free of commercial bias.

        AUA DISCLOSURE POLICY: 

        All persons in a position to control the content of an educational activity (i.e., activity planners, presenters, authors) are required to disclose to the provider any relevant financial relationships with any commercial interest. The AUA must determine if the individual’s relationships may influence the educational content and resolve any conflicts of interest prior to the commencement of the educational activity. The intent of this disclosure is not to prevent individuals with relevant financial relationships from participating, but rather to provide learners information with which they can make their own judgments.

        MITIGATION OF IDENTIFIED CONFLICT OF INTEREST: 

        All disclosures will be reviewed by the AUA Conflict of Interest (COI) Review Work Group for identification of conflicts of interest. The AUA COI Review Work Group, working with the program directors and/or editors, will document the mechanism(s) for management and mitigation of the conflict of interest and final approval of the activity will be documented prior to implementation. Any of the mechanisms below can/will be used to mitigate conflict of interest:

        • Peer review for valid, evidence-based content of all materials associated with an educational activity by the course/program director, editor, and/or AUA COI Review Work Group.
        • Limit content to evidence with no recommendations
        • Introduction of a debate format with an unbiased moderator (point-counterpoint)
        • Inclusion of moderated panel discussion
        • Publication of a parallel or rebuttal article for an article that is felt to be biased
        • Limit equipment representatives to providing logistics and operation support only in procedural demonstrations
        • Divestiture of the relationship by faculty

        OFF-LABEL OR UNAPPROVED USE OF DRUGS OR DEVICES: 

        The audience is advised that this continuing medical education activity may contain reference(s) to off-label or unapproved uses of drugs or devices. Please consult the prescribing information for full disclosure of approved uses.

        AUA PARTICIPANT INFORMATION & POLICIES

        Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the AUA.

        Consent to Use of Photographic Images: Attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the attendee's image or voice in photographs and electronic reproductions of such meetings and activities.

        Audio, Video and Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms.

        Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the American Urological Association.

        Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, please see the registration desk.

        Available Credit

        • 1.00 AMA PRA Category 1 Credit™
        • 1.00 Non-Physician Participation
        Please login or register to take this course.

        To join the webinar on Monday, June 28, 2021:

        1. Click on the TAKE COURSE button.

        2. Click "Live Webinar" on the left hand navigation. 

        3. Click "Start" to view the webinar live stream and participate using the "Chat" and "Q&A" features. 

        Registration for this course is complimentary. However should you need to cancel your participation for any reason, please let us know at least two weeks before the course by contacting education@auanet.org. 

        Attendee Information & Policies 

        AUA Anti-Harassment Policy 

        AUA Commitment: AUA is committed to providing a safe and productive meeting environment that fosters open dialogue and the exchange of scientific ideas and is free of harassment and discrimination. All meeting participants are expected to behave professionally and treat others with respect, follow venue rules, and alert AUA staff or security of any dangerous situations or anyone in distress. 

        Reporting Harassment: It is the policy of the AUA that all meeting participants will enjoy an environment free from discrimination, harassment or retaliation. Harassing or offensive behavior by meeting participants will not be tolerated. If an individual experiences or witnesses harassment, he or she should contact Janet Skorepa, AUA EVP, at jskorepa@AUAnet.org or Diane Bieri, AUA General Counsel, at dbieri@AUAnet.org or use a venue phone and ask for security if he or she feels unsafe. All complaints will be treated seriously and responded to promptly. 

        The AUA reserves the right to take any action deemed necessary and appropriate, including refusing or revoking the registration of any individual, without refund, as long as such refusal is consistent with applicable law and AUA policy. 

        Disclaimer: The opinions and recommendations expressed by faculty, authors and other experts whose input is included in this program are their own and do not necessarily represent the viewpoint of the American Urological Association (AUA). 

        Consent to Use of Photographic Images: Registration and attendance at or participation in AUA meetings and other activities constitutes an agreement by the registrant to AUA's use and distribution (both now and in the future) of the registrant or attendee's image or voice in photographs, videotapes, electronic reproductions, and audiotapes of such events and activities. 

        Audio, Video, Photographic Equipment: The use of audio, video and other photographic recording equipment by attendees is prohibited inside AUA meeting rooms. 

        Reproduction Permission: Reproduction of written materials developed for this AUA course is prohibited without the written permission from individual authors and the AUA. 

        Special Assistance/Dietary Needs: The AUA complies with the Americans with Disabilities Act §12112(a). If any participant is in need of special assistance or has any dietary restrictions, a written request should be submitted at least one month in advance. For additional assistance with your request please call 1-800-908-9414.